References
high-density lipoprotein
INSULIN RESISTANCE
A study designed as a randomized, double-blind, placebo-controlled parallel-group study is shown as a flow diagram. A total of 85 participants were randomized into two groups at baseline (W0): 42 participants were in the placebo group and 43 participants were in the treatment group. The intervention took 8 weeks (W8) and the same parameters were measured at W0 and W8. Abbreviations: W, week.Effect of supplementation on hs-CRP levels (Correlations were conducted at study start (W0) (Subgroup analysis (Participants’ baseline characteristics, blood biomarkers results, and the FFQ (screening).Values are expressed as mean ± standard deviation (SD). Abbreviations: BMI, body mass index; hs-CRP, high-sensitivity C-reactive protein; γ-GT, gamma-glutamyl transferase; AST, aspartate aminotransferase; ALT, alanine transaminase; HOMA index, Homeostasis Model Assessment for Insulin Resistance; HDL, high-density lipoprotein; LDL, low-density lipoprotein; FFQ, Food Frequency Questionnaire. Statistics: Comparison of groups revealed no difference for all parameters listed in the table (Laboratory parameters before and after the intervention and fatty acid composition in plasma at weeks 0 and 8.Abbreviations; hs-CRP, high-sensitivity C-reactive protein; IL-, Interleukin; BMI, body mass index; HOMA, Homeostasis Model Assessment for Insulin Resistance. Statistics: * differences between week 0 and W8 within the placebo and treatment groups and 